Global Commercial Roadmap For An Asset Case Study

Global Commercial Roadmap Asset Case Study Objective:

To develop a comprehensive commercial roadmap for the life of an asset, including key activities and their timing, ownership and budget constraints.

Methodology:

  • Reviewed and benchmarked all commercial activities by stage of an asset

  • Identified best practices by size of the company as well as therapeutic area

  • Interviewed key stakeholders on global and affiliate roles to understand pain points and potential best practices

  • Aligned activities by stage gate and built in key transition points across global and affiliate teams

  • Conducted workshops to socialize details of commercial roadmap

Value Added:

  • Comprehensive commercial roadmap for the life of an asset, including list of global and affiliate roles and responsibilities

  • Conducted pilot workshops to align affiliate teams

  • Integrated launch excellence framework with commercial roadmap

Latest Blogs

Planning for 505(b)2 Commercial Success

October 17, 2018
Unlike generics and biosimilars, 505(b)2 regulatory products likely involve a unique claim. While 505(b)...
Read more

Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices

February 12, 2018
The impact of drug shortages is not new within the healthcare system, particularly at the hospital level...
Read more

FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic Manufacturers

January 24, 2018
Citizen petitions have historically been a tool in the brand manufacturer’s toolkit of “product life...
Read more

The FDA approved Dupixent for moderate-to-severe atopic dermatitis

April 14, 2017
  The FDA approved Dupixent On March 28th, the FDA approved Dupixent for moderate-to-severe atopic ...
Read more